LDC7559 (Cat.No:I019407) is a small molecule inhibitor that targets the enzyme lysine-specific demethylase 1 (LSD1). LSD1 is involved in epigenetic regulation and has been implicated in various diseases, including cancer. LDC7559 selectively inhibits LSD1 activity, leading to the modulation of gene expression and potential therapeutic effects in certain disease conditions.
| Catalog Number | I019407 |
| CAS Number | 2407782-01-6 |
| Molecular Formula | C₂₀H₁₉N₃O₃ |
| Purity | ≥95% |
| Reference | [1]. Spel L, et al. Gasdermin D opens the way for NETs. Nat Rev Rheumatol. 2018 Dec;14(12):690-692.<br>[2]. Sollberger G, et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci Immunol. 2018 Aug 24;3(26). pii: eaar6689.<br>[3]. Ankit Pandeya, et al. Gasdermin D (GSDMD) as a New Target for the Treatment of Infection. Medchemcomm. 2019 Apr 4;10(5):660-667. |
